OptimizeRx Launches CopayCue™, a Next-Generation Copay Activation Solution Powered by Real-Time Prescribing Intent

About this update from Optimizerx Corporation

Enhanced technology delivers brand savings offers directly within the prescribing workflow, when HCP intent is highest WALTHAM, Mass., June 30, 2026 (GLOBE NEWSWIRE) -- OptimizeRx Corp. (the "Company") (Nasdaq: OPRX), a leading provider of healthcare technology solutions helping life sciences companies reach and engage healthcare professionals (HCPs) and patients at the most important decision points, today announced the launch of CopayCue™, designed to make brand savings offers more transparent for physicians at the point of prescribing. CopayCue is a next-generation enhancement to OptimizeRx's foundational Financial Assistance solution, using verified, real-time HCP prescribing intent data to deliver brand savings information, such as copay cards and affordability resources, directly within the e-prescribing workflow. Overcoming the Affordability Barrier with Real-Time Intent Data Medication affordability impacts both HCP prescribing decisions and patient access to therapy, with 43% of U.S. adults reporting they have not taken their medication as prescribed due to cost. And for newly launched drugs, nearly two thirds of prescriptions go unfilled in their first year on the market. The cost to the U.S. health system of non-adherence has been estimated at $100-$300 billion annually. Life sciences organizations invest heavily in brand awareness marketing and financial support programs only to lose patients when they go to fill prescriptions at the pharmacy. When savings information is connected to the prescribing workflow, it can increase brand sentiment and conversion, drive program utilization, and ensure patients have access to the intended therapies as prescribed by their physicians. Using real-time data signals from OptimizeRx's proprietary, best-in-class network of more than 400 electronic health record (EHR) and e-prescribing platforms, CopayCue activates brand savings offers at the precise moment an HCP demonstrates intent to prescribe a specific therapy. It enables life sciences organizations to: OptimizeRx data demonstrates the impact of affordability engagement within clinical workflows. CopayCue has been shown to increase prescription lift by 4-5% over EHR banners alone, and standalone programs have achieved an average prescription lift of 11.5%.

View stock analysis, news, and events for Optimizerx Corporation